Gujarat Terce Laboratories Limited (BOM:524314)
India · Delayed Price · Currency is INR 39.75
+1.05 (2.71%)
At close: Aug 17, 2026
BOM:524314 Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 22.02 | -9.79 | 2.44 | -16.72 | 8.72 |
Depreciation & Amortization | 4.23 | 3.85 | 3.68 | 3.65 | 2.76 |
Loss (Gain) From Sale of Assets | -0.03 | - | - | 0.04 | - |
Loss (Gain) From Sale of Investments | -0.56 | -0.11 | - | - | - |
Other Operating Activities | 8.43 | 44.44 | 6.96 | -6.08 | 0.94 |
Change in Accounts Receivable | 2.02 | 5.95 | 23.23 | -25.11 | -3 |
Change in Inventory | -0.48 | 2.51 | 4.45 | 20.01 | -26.92 |
Change in Accounts Payable | -20.35 | -10.99 | -12.13 | 18.26 | 11.76 |
Change in Other Net Operating Assets | 1.87 | -5.26 | -2.63 | 6.22 | 1.3 |
Operating Cash Flow | 17.15 | 30.59 | 26 | 0.27 | -4.43 |
Operating Cash Flow Growth | -43.95% | 17.67% | 9636.70% | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -0.31 | - | -0.74 | -0.63 | -21.14 |
Sale of Property, Plant & Equipment | 0.09 | 3.47 | 0.02 | - | - |
Investment in Securities | -7.81 | -2.31 | -0.01 | -0.01 | - |
Other Investing Activities | 6.95 | 3.39 | -3.86 | 6.79 | 12.46 |
Investing Cash Flow | -1.08 | 4.55 | -4.58 | 6.15 | -8.68 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | 8.43 | - | - | 14.39 | 0.59 |
Long-Term Debt Issued | - | - | - | - | 18.75 |
Total Debt Issued | 8.43 | - | - | 14.39 | 19.35 |
Short-Term Debt Repaid | - | -25.39 | -28.72 | - | - |
Long-Term Debt Repaid | -8.38 | -7.36 | -5.34 | -8.39 | - |
Total Debt Repaid | -8.38 | -32.75 | -34.06 | -8.39 | - |
Net Debt Issued (Repaid) | 0.05 | -32.75 | -34.06 | 6 | 19.35 |
Issuance of Common Stock | 10.49 | - | - | - | - |
Other Financing Activities | -5.8 | 4.5 | -6.76 | -7.21 | -4.01 |
Financing Cash Flow | 4.74 | -28.25 | -40.82 | -1.21 | 15.34 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Cash Flow | 20.8 | 6.89 | -19.4 | 5.21 | 2.23 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 16.84 | 30.59 | 25.26 | -0.36 | -25.57 |
Free Cash Flow Growth | -44.95% | 21.11% | - | - | - |
Free Cash Flow Margin | 3.55% | 6.09% | 5.27% | -0.08% | -6.37% |
Free Cash Flow Per Share | 2.24 | 4.12 | 3.40 | -0.05 | -3.45 |
Levered Free Cash Flow | 5.86 | 55.39 | 17.55 | 2.09 | -33.07 |
Unlevered Free Cash Flow | 6.84 | 57.65 | 21.48 | 6.27 | -30.99 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 1.57 | 3.62 | 6.28 | 6.68 | 3.33 |
Cash Income Tax Paid | - | 0.84 | - | 0.35 | 1.01 |
Change in Working Capital | -16.94 | -7.8 | 12.92 | 19.38 | -16.85 |